Shehadeh Ahmad, Al-Qawasmi Muhamad, Al Btoush Omar, Obeid Zeinab
Department of Orthopedics, King Hussein Cancer Center, Queen Rania St. 202, Amman 11941, Jordan.
Department of Diagnostic Radiology, King Hussein Cancer Center, Queen Rania St. 202, Amman 11941, Jordan.
J Clin Med. 2022 Nov 14;11(22):6734. doi: 10.3390/jcm11226734.
Background: Expandable distal femur endoprosthesis (EDFE) is commonly used to compensate for the loss of the distal femoral epiphyseal plate in skeletally immature children who have undergone surgical resection of bone malignancies. However, the effect of the passive tibial component of the EDFE on tibial growth has not been extensively studied in the literature. This study aims to delineate the type, frequency, and associated risk factors of multiplanar proximal tibial deformities in skeletally immature children following the use of the expandable distal femur endoprosthesis (EDFE). Moreover, we plan to detect how these deformities influence the long-term functionality of the endoprosthesis in defining the need for subsequent implant revision or further surgical management. Patients and Methods: A total of 20 patients aged (7−12) years underwent expandable distal femur replacement. Two types of implants were used: Juvenile Tumor System (JTS) non-invasive prosthesis in 14 patients, and Modular Universal Tumor and Revision System (MUTARS)® Xpand Growing Prostheses in six patients. A scanogram and CT scan documented the measurements of longitudinal and multiplanar growth as leg length discrepancy (LLD), femur length discrepancy (FLD), tibia length discrepancy (TLD), and the yield values of rotational, sagittal, and coronal deformities of the tibia. The patients were followed up to assess the need for further management. Sex, age, size of tibial plate perforation, and type of implant used were studied for possible correlation with deformities or growth disturbance. Results: The patients were followed up for a mean of 3 (2−7) years. A total of 14 patients, (10 JTS, 4 implant cast) had a tibial deformity and/or growth disturbance. A single patient was found to have all deformities (growth, rotational, coronal, and sagittal). Fourteen patients were found to have an LLD ranging from 5.3 to 59 mm (median 21 mm), 12 had a TLD from 3 to 30 mm, (median 10 mm), and 11 patients showed evidence of malrotation from 6 to 32 degrees (median 11 degrees). TLD was found to contribute entirely to LLD in three patients, and >50% of LLDs in seven patients. All LLDs were treated conservatively, except in three patients; two received contralateral tibia epiphysiodesis and one received revision with a new implant. A single patient had a posterior tibia slope angle (PTSA) of −2.8 degrees, and three patients had a coronal deformity with a mean medial proximal tibia angle (MPTA) of 80.3 (77−83 degrees). Conclusions: Tibial growth disturbance and multiplanar deformities occur in the majority of patients following EDFE replacement, exacerbating LLD. Yet, these disturbances may be well tolerated, managed conservatively, and rarely mandate endoprosthetic revision or subsequent corrective surgery. Age at the time of surgery was found to be the only significant contributor to the development of tibia growth disturbance.
可扩张型股骨远端假体(EDFE)常用于补偿骨骼未成熟儿童因骨恶性肿瘤手术切除导致的股骨远端骨骺板缺失。然而,EDFE的被动胫骨组件对胫骨生长的影响在文献中尚未得到广泛研究。本研究旨在描述骨骼未成熟儿童使用可扩张型股骨远端假体(EDFE)后胫骨近端多平面畸形的类型、频率及相关危险因素。此外,我们计划检测这些畸形如何影响假体的长期功能,以确定是否需要后续的植入物翻修或进一步的手术治疗。
共有20例年龄在7至12岁的患者接受了可扩张型股骨远端置换术。使用了两种类型的植入物:14例患者使用了青少年肿瘤系统(JTS)非侵入性假体,6例患者使用了模块化通用肿瘤与翻修系统(MUTARS)® Xpand生长型假体。通过扫描图和CT扫描记录纵向和多平面生长的测量数据,包括腿长差异(LLD)、股骨长度差异(FLD)、胫骨长度差异(TLD)以及胫骨旋转、矢状面和冠状面畸形的屈服值。对患者进行随访以评估是否需要进一步治疗。研究了性别、年龄、胫骨板穿孔大小和使用的植入物类型与畸形或生长障碍的可能相关性。
患者平均随访3(2至7)年。共有14例患者(10例JTS,4例植入石膏)出现胫骨畸形和/或生长障碍。发现1例患者存在所有畸形(生长、旋转、冠状面和矢状面)。发现14例患者的LLD范围为5.3至59毫米(中位数21毫米),12例患者的TLD为3至30毫米(中位数10毫米),11例患者显示有6至32度的旋转不良(中位数11度)。发现3例患者的LLD完全由TLD导致,7例患者的LLD超过50%由TLD导致。除3例患者外,所有LLD均采用保守治疗;2例接受对侧胫骨骨骺阻滞术,1例接受新植入物翻修术。1例患者的胫骨后倾角(PTSA)为 -2.8度,3例患者存在冠状面畸形,胫骨近端内侧平均角(MPTA)为80.3(77至83度)。
大多数患者在EDFE置换后出现胫骨生长障碍和多平面畸形,加剧了LLD。然而,这些障碍可能耐受性良好,可采用保守治疗,很少需要进行假体翻修或后续矫正手术。发现手术时的年龄是胫骨生长障碍发生的唯一重要因素。